Pharma & Biotech

While Bluejay Diagnostics continues to make tangible progress in the clinical development of its sepsis diagnostic technology, its shares are...

Bionxt Solutions shares find themselves caught between conflicting market forces. While recent corporate developments point to strengthening fundamentals, technical indicators...

The artificial intelligence healthcare specialist Healwell AI finds itself navigating a significant crisis of investor confidence, a situation made more...

In a surprising turn of events, Danish pharmaceutical giant Novo Nordisk has withdrawn from the high-stakes bidding competition for US...

After an extended period of decline, Bristol-Myers Squibb shares are showing signs of a potential turnaround. A combination of robust...

In the competitive landscape of biotechnology, two giants command significant attention: Vertex Pharmaceuticals and Regeneron Pharmaceuticals. Both companies have established...

Investors are closely monitoring Bayer as the company approaches the release of its third-quarter financial report this Wednesday. The pharmaceutical...

Sangamo Therapeutics finds itself navigating perilous financial waters, with its stock experiencing a dramatic 21% decline following disappointing quarterly results...

Viking Therapeutics has captured significant market attention following the release of impressive clinical trial results for its obesity treatment candidate...

The pharmaceutical sector is witnessing unprecedented excitement around innovative obesity treatments, with Eli Lilly positioned squarely at the epicenter of...